GENinCode PLC GENI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX0.63
- Day Range
- GBX0.60–0.65
- 52-Week Range
- GBX0.59–4.90
- Bid/Ask
- GBX0.60 / GBX0.65
- Shares Outstanding
- 753.04M
- Market Cap
- GBX452.35M
- Volume/Avg
- 215,053 / 3M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.16
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
GENinCode PLC principal activity is the development and commercialisation of clinical genetic tests, to provide predictive analysis of risk to a patient's health based on their genes. The company has one operating segment. The company has presence in Spain, UK, United States, Italy, Germany, and Rest of World. The company generates majority of revenue from Spain. Its commercial products are CE-Marked, with CARDIO inCode, THROMBO inCode, and LIPID inCode.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 39
- Website
- https://www.genincode.com
Valuation
|
Metric
|
GENI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 10.35 |
Price/Sales | 1.16 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
GENI
|
|---|---|
Quick Ratio | 2.16 |
Current Ratio | 2.22 |
Interest Coverage | — |
Quick Ratio
GENI
Profitability
|
Metric
|
GENI
|
|---|---|
Return on Assets (Normalized) | −135.41% |
Return on Equity (Normalized) | −1,460.13% |
Return on Invested Capital (Normalized) | −262.12% |
Return on Assets
GENI
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|@dtY!gs | LOCK|F?L | $245B | |||
| Danaher Corp
DHR
| LOCK|#cF<%#@x | LOCK|bgB | $156B | |||
| Agilent Technologies Inc
A
| LOCK|^f@b$%$ | LOCK|TQr | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|T<Pw^@@ | LOCK|^h#^X | $43B | |||
| Waters Corp
WAT
| LOCK|t$>Lfp | LOCK|$< | $42B | |||
| Illumina Inc
ILMN
| LOCK|Q>@MXTw | LOCK|!xMv$ | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|p&p&?^%M | LOCK|%H& | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|Np#v^!s | LOCK|?@%s | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|d^@KB$m | LOCK|L^?T$ | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|w>NpHZKj | LOCK|h$LM& | $26B |
United States